Advances in nanotechnology, lipid-based carriers, and mucosal absorption represent active areas of study to bridge the gap between oral feasibility and systemic efficacy
Randomised controlled trials of glucagon-like peptide 1 (GLP-1)-based therapies showed high glycaemic efficacy with clinically meaningful weight loss, and have been considered as game-changers in the diabesity population
Tranexamic Acid (1%): Helps visibly fade the look of persistent discoloration and uneven tone
Emerging research has also explored its use as a protective agent against UV-induced DNA damage, which may lower skin cancer risks
For example, one study on weight loss showed that it actually causes an increase in Lp(a) levels for people with LPA variants while at the same time reducing other cardiovascular disease risk factors.[ref] Now lets take a look at ways you can lower your Lp(a) levels
doi: 10.1016/S2213-8587(21)00002-4 3 BellisSAKuhnIAdamsSMullarkeyLHollandA